#TYME TECHNOLOGIES INC HOW TO#
#TYME TECHNOLOGIES INC FULL#
#TYME TECHNOLOGIES INC CODE#
#TYME TECHNOLOGIES INC FREE#

#TYME TECHNOLOGIES INC FULL#

The company is currently conducting a Phase II trial in prostate cancer.Д¬lick Here to get the full Stock Report for Tyme Technologies Inc stock.

#TYME TECHNOLOGIES INC FREE#

SM 88, its proprietary drug candidate compound, is a novel compound that has the potential to alter defenses to oxidative stress and increase free radical availability to the cancer cell. The company is focused on the development and commercialization of targeted cancer therapeutics with a broad range of oncology indications for humans. Tyme Technologies Inc is the U.S based clinical-stage biotechnology company. To see InvestorsObserver's Sentiment Score for Tyme Technologies Inc click here. It offers a clinical program named SM-88 which is a novel. TYME lost -$0.18 per share in the over the last 12 months. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. Over the past year the S&P 500 has gained 31.66% while TYME is higher by 3.00%. Stock analysis for Tyme Technologies Inc (TYME:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company.

TYME is higher by $0.03 from the previous closing price of $1.00 on volume of 672,870 shares. Tyme Technologies Inc (TYME) stock is higher by 3.28% while the S&P 500 has fallen -0.06% as of 12:48 PM on Thursday, Oct 21. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price. Our system also uses the options market in order to receive additional signals on current sentiments. The company is focused on creating medicines which specialize in the bodys immune system to treat diseases. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. NEW YORK, NY / ACCESSWIRE / Febru/ Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Tyme Technologies, Inc.('Tyme' or the 'Company'). InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume.

Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. Incorporated 2014 Employees 13.00 Location Tyme Technologies Inc C/O Crone Kline Rinde Llp 488 Madison Avenue, 12Th Floor NEW YORK 10022 United States USA Phone +1 (212) 400-6900 Fax +1 (845). At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. There is no information about the health of profitability of the underlying company in our sentiment score.ДЄs a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.Д¬hanges in price are generally the best indicator of sentiment for a particular stock. Sentiment is a very short-term indicator that is entirely technical. (TYME) is a biotechnology company focused on developing cancer metabolism-based therapies for a solid tumors and hematologic cancers.

#TYME TECHNOLOGIES INC HOW TO#

Statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat,Д¬lick here for more on how to use these ratings.See Full TYME Report What is Stock Sentiment?

Companies with ratings are not formally covered by a Morningstar analyst, but are Peer companies that do receive analyst-driven ratings. Morningstar Quantitative ratings for equities (denoted on this page by ) are generated using an algorithm that compares companies that are not under analyst coverage to

#TYME TECHNOLOGIES INC CODE#

Davidson is guided by Morningstar, Inc.'s Code of EthicsДЄnd Personal Securities Trading Policy in carrying out his responsibilities. Is responsible for overseeing the methodology that supports the quantitative fair value. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate isДЄttributed to however, Mr.

Tyme technologies inc